Belgian Cancer Registry, Rue Royale 215, Koningstraat 215 - 1210, Bruxelles, Brussel, Belgium.
Belgian Health Care Knowledge Centre (KCE). Centre Administratif Botanique, Doorbuilding, Boulevard du Jardin Botanique 55, B-1000, Brussels, Belgium.
Eur J Surg Oncol. 2019 Dec;45(12):2443-2450. doi: 10.1016/j.ejso.2019.05.017. Epub 2019 May 16.
The existence of a relationship between hospital surgical volume and outcome after lung cancer surgery remains an ongoing debate. We aimed to evaluate the association between volume and 60-day mortality, 1- and 3-year observed survival (OS) in non-small cell lung cancer (NSCLC) patients in Belgium.
Patients diagnosed with NSCLC in 2010-2011 were identified in the database of the Belgian Cancer Registry, excluding patients with multiple tumours. Regression models were applied to assess the relationship between hospital surgical volume, 60-day mortality and 1- and 3-year OS, adjusting for different patient and tumour characteristics. Surgical volume was taken into account as a continuous variable in the models.
In 2010-2011 a total of 9,817 patients with NSCLC were diagnosed in Belgium and 2,084 of them underwent surgery. After adjusting for patient and tumour characteristics, a relationship between hospital surgical volume and patients' outcome was found. Postoperative mortality and survival improved with increasing annual surgical volume up to 10 interventions. However, no further gain in outcome has been observed above 10. While the 60-day postoperative mortality is 3.5% for hospitals with an annual volume larger than 10, the predicted mortality rate for a hospital with an annual volume of only 5 interventions is 6.5%. Similar results were observed for 1- and 3-year OS.
In Belgium, a higher hospital surgical volume is associated with improved outcome in NSCLC patients after surgical resection. Minimally 10 surgical interventions per year seem to be required to achieve an optimal performance.
医院手术量与肺癌手术后结果之间的关系仍然存在争议。本研究旨在评估比利时非小细胞肺癌(NSCLC)患者的手术量与 60 天死亡率、1 年和 3 年观察生存率(OS)之间的关系。
在比利时癌症登记数据库中确定了 2010-2011 年诊断为 NSCLC 的患者,排除了患有多个肿瘤的患者。回归模型用于评估医院手术量、60 天死亡率和 1 年和 3 年 OS 之间的关系,同时调整了不同的患者和肿瘤特征。手术量在模型中作为连续变量考虑。
2010-2011 年,比利时共诊断出 9817 例 NSCLC 患者,其中 2084 例接受了手术。在调整了患者和肿瘤特征后,发现医院手术量与患者的结果之间存在关系。术后死亡率和生存率随着年度手术量的增加而提高,最高可达 10 次干预。然而,在 10 次以上的手术量中,没有观察到进一步的获益。对于每年手术量大于 10 的医院,术后 60 天的死亡率为 3.5%,而每年手术量仅为 5 次的医院的预测死亡率为 6.5%。1 年和 3 年 OS 也观察到了类似的结果。
在比利时,较高的医院手术量与 NSCLC 患者手术后的生存结果改善相关。每年至少需要进行 10 次手术干预,才能达到最佳效果。